Mr. M is a 66 year old male admitted with decreased LOC. He has a history of chronic bronchitis and heart failure. His vital signs are: T=102, HR= 104, RR-28 and shallow, and BP=90/60.

His ABG reveals:

• pH 7.2
• paCO2 75
• HCO3 26

What are some common causes that would cause this?

Rationale:

A. Increasing the ventilator rate would enhance ventilation (removal of CO2), but this patient already has a normal PaCO2. There is no evidence of respiratory acidosis or hypercapnia, so adjusting the rate would not improve the hypoxemia.

B. Lowering the rate would further reduce CO2 removal, which is unnecessary because CO2 levels are normal. This adjustment would not improve oxygenation.

C. PEEP (positive end-expiratory pressure) helps keep alveoli open during expiration, improving oxygenation. Reducing PEEP could worsen alveolar collapse and further decrease PaO2.

D. Increase tidal volume is not the first intervention. The patient’s tidal volume of 550 mL for a 75 kg patient is about 7.3 mL/kg, which is within the recommended range (6–8 mL/kg ideal body weight) for lung-protective ventilation. Increasing tidal volume could increase the risk of barotrauma or volutrauma without effectively improving oxygenation as the main problem is hypoxemia, not ventilation.

E. Fraction of inspired oxygen (FIO2) directly increases the amount of oxygen delivered to the alveoli and subsequently to the bloodstream. With a PaO2 of 49 mmHg, the patient is severely hypoxemic and at risk for tissue hypoxia, organ dysfunction, and cardiac compromise. Increasing FIO2 is the most immediate and appropriate intervention to improve oxygenation while continuing to monitor the patient. Once oxygenation stabilizes, other adjustments, such as increasing PEEP or optimizing positioning, may be considered if needed.

Rationale:

A. Neuromuscular blocking agents (NMBAs) do not relieve anxiety. They only paralyze skeletal muscles and do not affect the central nervous system’s perception of fear or distress.

B. NMBAs do not provide pain relief. A patient under the effects of an NMBA may still experience pain but cannot move or communicate discomfort. Analgesics must be administered separately.

C. NMBAs do not induce sedation. The patient remains fully conscious and aware unless sedatives or anesthetics are given concurrently.

D. Neuromuscular blocking agents only cause skeletal muscle paralysis. They do not affect pain perception, consciousness, or anxiety. Because patients cannot move or communicate while paralyzed, it is essential to provide concurrent sedation and analgesia to prevent severe distress.